{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:34:00Z","timestamp":1758944040845},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives:<\/jats:title>\n                  <jats:p>Flow cytometry immunophenotyping has been suggested as an adjunctive technique in the evaluation of myeloid malignancies, especially in the myelodysplastic syndromes. However, its use has been limited due to complexity and cost restraints. The goal of this study is to attempt a simpler approach to flow cytometry immunophenotyping in myeloid neoplasms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>We analyzed bone marrow specimens of 45 selected patients and an additional 99 consecutive random patients using a limited antibody panel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Normal CD34-positive blasts show a characteristic pattern of CD13\/HLA-DR expression, with three readily identifiable subpopulations. In contrast, myeloid neoplasms frequently show loss of this heterogeneity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Analysis of a limited antibody panel with a focus on CD13\/HLA-DR expression provides relatively high specificity and sensitivity for the detection of myeloid neoplasms.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1309\/ajcp73qsllydegxk","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T22:19:05Z","timestamp":1408054745000},"page":"292-298","source":"Crossref","is-referenced-by-count":9,"title":["Loss of Blast Heterogeneity in Myelodysplastic Syndrome and Other Chronic Myeloid Neoplasms"],"prefix":"10.1093","volume":"142","author":[{"given":"Dragan","family":"Jevremovic","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Timm","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaaren K.","family":"Reichard","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Morice","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Viswanatha","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong L.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"key":"2023012005395299800_b1-1420292","article-title":"Myelodysplastic syndromes\/neoplasms, overview","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Brunning","year":"2008"},{"key":"2023012005395299800_b2-1420292","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/blood.V98.4.979","article-title":"Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome","volume":"98","author":"Stetler-Stevenson","year":"2001","journal-title":"Blood"},{"key":"2023012005395299800_b3-1420292","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cyto.b.20607","article-title":"Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia","volume":"80","author":"Della Porta","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"key":"2023012005395299800_b4-1420292","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1309\/AJCPFNF5MN1GDWKU","article-title":"The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders","volume":"134","author":"Harrington","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"2023012005395299800_b5-1420292","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cyto.b.21068","article-title":"Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic\/myeloproliferative neoplasms","volume":"84","author":"Kern","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"2023012005395299800_b6-1420292","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1309\/CAUT52HJ535P9UG2","article-title":"Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders","volume":"120","author":"Kussick","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"2023012005395299800_b7-1420292","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/leu.2008.49","article-title":"The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal\/reactive and myelodysplastic syndrome precursors","volume":"22","author":"Matarraz","year":"2008","journal-title":"Leukemia"},{"key":"2023012005395299800_b8-1420292","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2002-01-0222","article-title":"Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome","volume":"100","author":"Ogata","year":"2002","journal-title":"Blood"},{"key":"2023012005395299800_b9-1420292","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/10428194.2012.718341","article-title":"Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group","volume":"54","author":"van de Loosdrecht","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2023012005395299800_b10-1420292","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.leukres.2011.09.015","article-title":"Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS","volume":"36","author":"Westers","year":"2012","journal-title":"Leuk Res"},{"key":"2023012005395299800_b11-1420292","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2012.30","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group","volume":"26","author":"Westers","year":"2012","journal-title":"Leukemia"},{"key":"2023012005395299800_b12-1420292","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.2365","article-title":"Critical assessment of automated flow cytometry data analysis techniques","volume":"10","author":"Aghaeepour","year":"2013","journal-title":"Nat Methods"},{"key":"2023012005395299800_b13-1420292","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tibtech.2013.04.008","article-title":"Overview of clinical flow cytometry data analysis: recent advances and future challenges","volume":"31","author":"Pedreira","year":"2013","journal-title":"Trends Biotechnol"},{"key":"2023012005395299800_b14-1420292","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cyto.a.21148","article-title":"Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data","volume":"81","author":"Fiser","year":"2012","journal-title":"Cytometry A"},{"key":"2023012005395299800_b15-1420292","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1309\/AJCPAGVO27RPTOTV","article-title":"Diagnostic potential of CD34+ cell antigen expression in myelodysplastic syndromes","volume":"138","author":"De Smet","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"2023012005395299800_b16-1420292","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3324\/haematol.2008.004085","article-title":"Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes","volume":"94","author":"Goardon","year":"2009","journal-title":"Haematologica"},{"key":"2023012005395299800_b17-1420292","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/10428194.2013.820291","article-title":"Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment","volume":"55","author":"Burbury","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"2023012005395299800_b18-1420292","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2002-01-0230","article-title":"Immunophenotypic clustering of myelodysplastic syndromes","volume":"100","author":"Maynadie","year":"2002","journal-title":"Blood"},{"key":"2023012005395299800_b19-1420292","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2009-08-239749","article-title":"Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment","volume":"115","author":"Westers","year":"2010","journal-title":"Blood"},{"key":"2023012005395299800_b20-1420292","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1309\/6PBP78G4FBA1FDG6","article-title":"Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia","volume":"124","author":"Kussick","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"2023012005395299800_b21-1420292","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1309\/J3ET7RXD1X4BKDLF","article-title":"Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common","volume":"125","author":"Pirruccello","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"2023012005395299800_b22-1420292","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood-2008-05-153700","article-title":"Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome","volume":"112","author":"Scott","year":"2008","journal-title":"Blood"},{"key":"2023012005395299800_b23-1420292","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.leukres.2009.01.012","article-title":"The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study","volume":"33","author":"Truong","year":"2009","journal-title":"Leuk Res"},{"key":"2023012005395299800_b24-1420292","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2007-07-098764","article-title":"Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry","volume":"111","author":"van de Loosdrecht","year":"2008","journal-title":"Blood"},{"key":"2023012005395299800_b25-1420292","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.leukres.2007.06.012","article-title":"Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls","volume":"32","author":"Stachurski","year":"2008","journal-title":"Leuk Res"},{"key":"2023012005395299800_b26-1420292","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cyto.b.21108","article-title":"Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS\u2014part V\u2014assay performance criteria","volume":"84","author":"Wood","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"2023012005395299800_b27-1420292","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjh.12435","article-title":"Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes","volume":"162","author":"Kulasekararaj","year":"2013","journal-title":"Br J Haematol"},{"key":"2023012005395299800_b28-1420292","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1309\/AJCPN4G1IZPABRLH","article-title":"A dissection of the CD45\/side scatter \u201cblast gate.\u201d","volume":"137","author":"Harrington","year":"2012","journal-title":"Am J Clin Pathol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/142\/3\/292\/48793322\/ajcp_142_3_292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/142\/3\/292\/48793322\/ajcp_142_3_292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T05:40:18Z","timestamp":1674193218000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/142\/3\/292\/1760616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,9,1]]},"published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcp73qsllydegxk","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,9,1]]},"published":{"date-parts":[[2014,9,1]]}}}